Market Tracker

04/20 5:15pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.24
Delayed Data
As of Apr 20
 +0.0226 / +1.02%
Today’s Change
1.35
Today|||52-Week Range
4.65
+31.76%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.22
Today’s open2.22
Day’s range2.20 - 2.25
Volume89,563
Average volume (3 months)375,270
Market cap$41.3M
Data as of 3:59pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+34.26%
P/E ratioNM
Price/Sales1.27
Price/Book15.69

Competitors

 Today’s
change
Today’s
% change
OREXQOrexigen Therapeutic...-0.01-8.58%
PRPHProPhase Labs Inc0.000.00%
FCSCFibrocell Science In...-0.02-2.51%
PULMPulmatrix Inc+0.01+1.30%
Data as of 3:59pm ET, 04/20/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$26.8M
Annual profit (last year)-$12.0M
Net profit margin-44.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
CFO, Secretary &
Principal Accounting Officer
Andrew R. Boll
Corporate headquarters
San Diego, California

Forecasts